Microfluidics Market Analysis Report By Application, By Technology, By Material And Segment Forecasts From 2020 To 2027

Synopsis

With reference to the report published, the global microfluidics market size was prized by USD 13.5 billion in 2019. It is estimated to witness an 11.3% CAGR during the period of the forecast.

Drivers

Growth in the requirement for point-of-care (POC) apparatuses is estimated to considerably impel the market for microfluidics. Microfluidics-centered apparatuses require a small size sample, used for understanding the facts. The use of microfluidics has made possible, the standard procedures of the laboratory to be transferred to lab-on-a-chip.

Moreover, the market is powered, by means of the demand for high-pitched throughput methodologies of screening, scrutiny of small quantity samples, the requirement for In Vitro Diagnostics (IVD), in addition to improvement of superior lab-on-a-chip equipment. Furthermore, microfluidics presents a greater yield on investments, plus assists in controlling the cost by means of reducing mistakes.

Microfluidics is effectively applied in the making of extensive varieties of marketable products. Such as, incorporated fluidic circuits, produced by Fluidigm Corporation, offers a greater throughput of the samples, inexpensive solutions for the complex solo nucleotide polymorphism genotyping. Likewise, Quanta Life proposes drop-centered microfluidics resolution to perform digital PCR for the quantization of nucleic acids.

Paper sourced investigative analysis is estimated to increase the importance, during the neighboring future. The experts from the University of Washington and Harvard University are developing a function, used for the paper sourced microfluidics, designed for the testing of nucleic acid. Besides, they have received funding from the Defense Advanced Research Projects Agency (DARPA), in favor of this workout. This will assist medicinal practitioners to identify pathogenic DNA, used for the identification of an extensive variety of chronic sicknesses and infectivity.

Effect of Covid-19

Due to the increasing infection of Covid-19, the fear about the scarcity of necessary life-saving apparatuses, as well as additional crucial remedial provisions, so as to avert the distribution of this pandemic, as well as offer the best possible care to the infected patients moreover broadens. The ventilators perform such as the fundamental preference of the treatment for the Covid-19 patients, those might need essential treatment. Furthermore, there is an earnest requirement for speeding up the procedure of manufacturing a variety of test kits.

Application Insight

In 2019, the lab-on-a-chip section retained the principal share in the microfluidics market and is estimated to sustain its supremacy, all through the period of forecast. In the area of molecular biology, lab-on-a-chip presents greater swiftness of discovery, even as keeping up the similar sensitivity throughout RNA or DNA intensification and discovery measures. Lab-on-a-chip, moreover, permits the speedy sequencing of DNA probe.

The non-medicinal function of lab-on-a-chip research concentrates on the mixture of chemicals. These methods experience quick heating and cooling procedure at a micro range point, thus permitting greater effectiveness for the duration of a chemical reaction. Therefore, a large amount of research has been carried out on make use of lab-on-a-chip as extremely parallelized as well as micro-sized microchemical reactors. Moreover, this procedure takes care of hazardous and volatile compounds.

Technology Insight

The sector of medical technology ruled the microfluidics market, centered on revenue. Microfluidics presents the three most important benefits to POC diagnostics. These are earlier turnaround period, lesser size of sample, as well as slighter test expenses. These paybacks are steadily being used for the growth of POC procedure, used for the analysis and revealing of a range of circumstances, from cancer to communicable disease.

Material Insight

In 2019, the polydimethylsiloxane (PDMS) centered microfluidics chips sector retained the maximum share of revenue and is estimated to display the highest CAGR for the duration of the forecast. PDMS is extensively utilized polymer, particularly in speedy prototyping microfluidics procedures. These polymers are extremely acceptable through the educational society, due to their easiness of production as well as low down price. But, these polymers are hydrophobic, which creates micro channels, hard to work in aqueous solutions since hydrophobic analytes are absorbed on the exterior of PDMS, finally interfering by the analysis. To tackle such problems, fresh PDMS exterior alterations are offered, to deal with the challenges, as a result of hydrophobicity.

Polymer-centered microfluidics procedures perform as a substitute to glass and silicon center microfluidics procedures. As compare with glass and silicon, these materials are reasonably priced, simple to access, strong, and necessitate speedy manufacturing procedures. Polymers are capable materials, in microfluidics chip function, since they can be utilized for bulk production by means of casting, supple lithography, injection molding, and hot embossing method.

Regional Insight

Owing to the regional existence of entrenched leaders of the market, increase in the figure of examination being carried out to improve optimization level of the sample, presentation of superior technology, and strong demand for POC diagnostics, North America was the major section in the microfluidics market. Furthermore, the energetic involvement of the research organizations, in this area, for the progress of novel microfluidics procedures, is estimated to uphold the supremacy of the region.

The Asia Pacific is expected to be the speedily developing market due to the advanced research infrastructure, reasonably priced manual labor, and acceptance of microfluidics podium. International companies have revealed their curiosity in spending in this intact market. Select BIO Microfluidics and Organ-on-a-Chip Asia planned a discussion in Japan to talk about new tools in the matter of Microfluidics, Lab-on-a-Chip, as well as Organ-on-a-Chip, in November 2019.

Companies

The companies are launching innovative products, to make stronger their position in the market. Dolomite Microfluidics launched µEncapsulator Systems, and its new microencapsulation system, in March 2019. The system is able to summarize almost 300,000 cells into the monodisperse drops, in a duration of just 15 minutes. Fluidigm Corporation introduced, in September 2019, a new microfluidics-centered workflow Advanta RNA-Seq NGS Library Prep Kit, intended for the groundwork of RNA sequencing libraries. This approach was intended at increasing Juno Microfluidics System’s use in greater throughput laboratories.

Some of the companies for the microfluidics market are:

    • Fluidigm Corporation
    • Cellix Ltd.
    • Biomérieux
    • Thermo Fisher Scientific
    • Life Technologies Corporation
    • Bio-Rad Laboratories, Inc.
    • PerkinElmer, Inc.
    • Illumina, Inc.
    • Micronit Micro Technologies B.V.
    • Elveflow
    • Qiagen
    • Abbott Laboratories
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • F. Hoffmann-La Roche Ltd.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For this study, Million Insight's has segmented the global microfluidics market report based on technology, application, material, and region:

• Technology Outlook (Revenue, USD Million, 2016 - 2027)
    • Medical/Healthcare
        • PCR & RT-PCR
        • Gel Electrophoresis
        • Microarrays
        • ELISA
        • Others
    • Non-Medical

• Application Outlook (Revenue, USD Million, 2016 - 2027)
    • Lab-on-a-chip
        • Medical
        • Non-Medical
    • Organs-on-chips
        • Medical
        • Non-Medical
    • Continuous-flow microfluidics
        • Medical
        • Non-Medical
    • Optofluidics and microfluidics
        • Medical
        • Non-Medical
    • Acoustofluidics and microfluidics
        • Medical
        • Non-Medical
    • Electrophoresis and microfluidics
        • Medical
        • Non-Medical

• Material Outlook (Revenue, USD Million, 2016 - 2027)
    • Silicon
    • Glass
    • Polymer
    • PDMS
    • Others

• Regional Outlook (Revenue, USD Million, 2016 - 2027)
    • North America
        • The U.S.
        • Canada
    • Europe
        • The U.K.
        • Germany
        • France
    • Asia Pacific
        • India
        • China
        • Japan
    • Latin America
        • Brazil
        • Mexico
    • Middle East & Africa
        • South Africa